Share of S. aureus infections resistant to methicillin in Iran, Islamic Republic of

Iran, Islamic Republic of: Share of S. aureus infections resistant to methicillin was 34.7% in 2022. ▼ Falling

Latest (2022)
34.7%
Change on year
up 5.8%
World rank
17th
of 45 countries
All-time high
44.1%
in 2020
All-time low
32.8%
in 2021
Years of data
5
2018–2022

Share of S. aureus infections resistant to methicillin in Iran, Islamic Republic of, 2018–2022

0102030402018202020222018: 38.5 %2019: 39.1 %2020: 44.1 %2021: 32.8 %2022: 34.7 %

Source: World Health Organization – processed by Our World in Data. Measured in %.

Analysis

Iran, Islamic Republic of recorded 34.7% for share of s. aureus infections resistant to methicillin in 2022.

Compared with earlier readings it is up 5.8% on the previous year and down 9.8% over five years.

Iran, Islamic Republic of ranks 17th of 45 countries on this measure, in the middle of the range.

Share of S. aureus infections resistant to methicillin in Iran, Islamic Republic of, year by year

Annual values for Share of S. aureus infections resistant to methicillin in Iran, Islamic Republic of, 2018 to 2022.
Year % Change
2018 38.5%
2019 39.1% +1.5%
2020 44.1% +12.7%
2021 32.8% -25.6%
2022 34.7% +5.8%

Averages by decade

DecadeAverage LowestHighest Years
2010s 38.8% 38.5% 39.1% 2
2020s 37.2% 32.8% 44.1% 3

Countries ranked near Iran, Islamic Republic of

  1. 14 Greece 41.1% compare
  2. 15 United Arab Emirates 39.9% compare
  3. 16 Indonesia 35.2% compare
  4. 18 Japan 33.9% compare
  5. 19 Argentina 32.8% compare
  6. 20 Italy 30.6% compare

See the full ranking of 45 places →

More reference data data for Iran, Islamic Republic of

All data for Iran, Islamic Republic of →

Frequently asked questions

What is share of s. aureus infections resistant to methicillin in Iran, Islamic Republic of?
Share of s. aureus infections resistant to methicillin in Iran, Islamic Republic of was 34.7% in 2022, according to World Health Organization – processed by Our World in Data.
What is the highest share of s. aureus infections resistant to methicillin recorded in Iran, Islamic Republic of?
The highest recorded value was 44.1% in 2020.
What is the lowest share of s. aureus infections resistant to methicillin recorded in Iran, Islamic Republic of?
The lowest recorded value was 32.8% in 2021.
How does Iran, Islamic Republic of rank for share of s. aureus infections resistant to methicillin?
Iran, Islamic Republic of ranks 17th out of 45 countries with data for 2022.
Where does this Iran, Islamic Republic of data come from?
The figures come from World Health Organization – processed by Our World in Data, published as part of Share of S. aureus infections resistant to methicillin. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of S. aureus infections resistant to methicillin in Iran, Islamic Republic of. Statizoid, drawing on World Health Organization – processed by Our World in Data. Retrieved 03 September 2026, from https://reference.statizoid.com/stat/share-of-s-aureus-bloodstream-infections-that-are-resistant-to-antibiotics/iran-islamic-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/share-of-s-aureus-bloodstream-infections-that-are-resistant-to-antibiotics/iran-islamic-rep/">Share of S. aureus infections resistant to methicillin in Iran, Islamic Republic of</a> — Statizoid

About this data

Indicator
Share of S. aureus infections resistant to methicillin
Unit
%
Source
World Health Organization – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
45 places, 273 data points, 2016–2022
Last refreshed

Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).